Selected research
Industry Growth & Trends
Global IVIg Liquid Industry Growth and Trends Forecast to 2032
Market perspective
The global IVIg Liquid market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for IVIg Liquid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for IVIg Liquid is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for IVIg Liquid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of IVIg Liquid include Takeda, Sichuan Yuanda Shuyang, Shanghai RAAS, Hualan Bio, Octapharma, LFB Group, Kedrion, Grifols and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global IVIg Liquid market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The IVIg Liquid market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global IVIg Liquid market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to IVIg Liquid.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global IVIg Liquid market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
IVIg Liquid Market by Company
Takeda
Sichuan Yuanda Shuyang
Shanghai RAAS
Hualan Bio
Octapharma
LFB Group
Kedrion
Grifols
CSL
CNBG
CBPO
BPL
Biotest
IVIg Liquid Segment by Type
50ml
25ml
IVIg Liquid Segment by Application
Autoimmune Disease
Immunodeficiency
Acute Infection
IVIg Liquid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IVIg Liquid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of IVIg Liquid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IVIg Liquid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IVIg Liquid manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of IVIg Liquid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50ml
- 25ml
Applications
- Autoimmune Disease
- Immunodeficiency
- Acute Infection
Companies covered
- Takeda
- Sichuan Yuanda Shuyang
- Shanghai RAAS
- Hualan Bio
- Octapharma
- LFB Group
- Kedrion
- Grifols
- CSL
- CNBG
- CBPO
- BPL
- Biotest
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global IVIg Liquid Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global IVIg Liquid Sales Estimates and Forecasts (2021-2032)
- 1.3 IVIg Liquid Market by Type
- 1.3.1 50ml
- 1.3.2 25ml
- 1.4 Global IVIg Liquid Market Size by Type
- 1.4.1 Global IVIg Liquid Market Size Overview by Type (2021-2032)
- 1.4.2 Global IVIg Liquid Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global IVIg Liquid Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America IVIg Liquid Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe IVIg Liquid Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific IVIg Liquid Sales Breakdown by Type (2021-2026)
- 1.5.4 South America IVIg Liquid Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa IVIg Liquid Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 IVIg Liquid Industry Trends
- 2.2 IVIg Liquid Industry Drivers
- 2.3 IVIg Liquid Industry Opportunities and Challenges
- 2.4 IVIg Liquid Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by IVIg Liquid Revenue (2021-2026)
- 3.2 Global Top Players by IVIg Liquid Sales (2021-2026)
- 3.3 Global Top Players by IVIg Liquid Price (2021-2026)
- 3.4 Global IVIg Liquid Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global IVIg Liquid Major Company Production Sites & Headquarters
- 3.6 Global IVIg Liquid Company, Product Type & Application
- 3.7 Global IVIg Liquid Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global IVIg Liquid Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 IVIg Liquid Players Market Share by Revenue in 2025
- 3.8.3 2025 IVIg Liquid Tier 1, Tier 2, and Tier 3
4 IVIg Liquid Regional Status and Outlook
- 4.1 Global IVIg Liquid Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global IVIg Liquid Historic Market Size by Region
- 4.2.1 Global IVIg Liquid Sales in Volume by Region (2021-2026)
- 4.2.2 Global IVIg Liquid Sales in Value by Region (2021-2026)
- 4.2.3 Global IVIg Liquid Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global IVIg Liquid Forecasted Market Size by Region
- 4.3.1 Global IVIg Liquid Sales in Volume by Region (2027-2032)
- 4.3.2 Global IVIg Liquid Sales in Value by Region (2027-2032)
- 4.3.3 Global IVIg Liquid Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 IVIg Liquid by Application
- 5.1 IVIg Liquid Market by Application
- 5.1.1 Autoimmune Disease
- 5.1.2 Immunodeficiency
- 5.1.3 Acute Infection
- 5.2 Global IVIg Liquid Market Size by Application
- 5.2.1 Global IVIg Liquid Market Size Overview by Application (2021-2032)
- 5.2.2 Global IVIg Liquid Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global IVIg Liquid Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America IVIg Liquid Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe IVIg Liquid Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific IVIg Liquid Sales Breakdown by Application (2021-2026)
- 5.3.4 South America IVIg Liquid Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa IVIg Liquid Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Takeda
- 6.1.1 Takeda Company Information
- 6.1.2 Takeda Business Overview
- 6.1.3 Takeda IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Takeda IVIg Liquid Product Portfolio
- 6.1.5 Takeda Recent Developments
- 6.2 Sichuan Yuanda Shuyang
- 6.2.1 Sichuan Yuanda Shuyang Company Information
- 6.2.2 Sichuan Yuanda Shuyang Business Overview
- 6.2.3 Sichuan Yuanda Shuyang IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sichuan Yuanda Shuyang IVIg Liquid Product Portfolio
- 6.2.5 Sichuan Yuanda Shuyang Recent Developments
- 6.3 Shanghai RAAS
- 6.3.1 Shanghai RAAS Company Information
- 6.3.2 Shanghai RAAS Business Overview
- 6.3.3 Shanghai RAAS IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Shanghai RAAS IVIg Liquid Product Portfolio
- 6.3.5 Shanghai RAAS Recent Developments
- 6.4 Hualan Bio
- 6.4.1 Hualan Bio Company Information
- 6.4.2 Hualan Bio Business Overview
- 6.4.3 Hualan Bio IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Hualan Bio IVIg Liquid Product Portfolio
- 6.4.5 Hualan Bio Recent Developments
- 6.5 Octapharma
- 6.5.1 Octapharma Company Information
- 6.5.2 Octapharma Business Overview
- 6.5.3 Octapharma IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Octapharma IVIg Liquid Product Portfolio
- 6.5.5 Octapharma Recent Developments
- 6.6 LFB Group
- 6.6.1 LFB Group Company Information
- 6.6.2 LFB Group Business Overview
- 6.6.3 LFB Group IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 LFB Group IVIg Liquid Product Portfolio
- 6.6.5 LFB Group Recent Developments
- 6.7 Kedrion
- 6.7.1 Kedrion Company Information
- 6.7.2 Kedrion Business Overview
- 6.7.3 Kedrion IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Kedrion IVIg Liquid Product Portfolio
- 6.7.5 Kedrion Recent Developments
- 6.8 Grifols
- 6.8.1 Grifols Company Information
- 6.8.2 Grifols Business Overview
- 6.8.3 Grifols IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Grifols IVIg Liquid Product Portfolio
- 6.8.5 Grifols Recent Developments
- 6.9 CSL
- 6.9.1 CSL Company Information
- 6.9.2 CSL Business Overview
- 6.9.3 CSL IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 CSL IVIg Liquid Product Portfolio
- 6.9.5 CSL Recent Developments
- 6.10 CNBG
- 6.10.1 CNBG Company Information
- 6.10.2 CNBG Business Overview
- 6.10.3 CNBG IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 CNBG IVIg Liquid Product Portfolio
- 6.10.5 CNBG Recent Developments
- 6.11 CBPO
- 6.11.1 CBPO Company Information
- 6.11.2 CBPO Business Overview
- 6.11.3 CBPO IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 CBPO IVIg Liquid Product Portfolio
- 6.11.5 CBPO Recent Developments
- 6.12 BPL
- 6.12.1 BPL Company Information
- 6.12.2 BPL Business Overview
- 6.12.3 BPL IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 BPL IVIg Liquid Product Portfolio
- 6.12.5 BPL Recent Developments
- 6.13 Biotest
- 6.13.1 Biotest Company Information
- 6.13.2 Biotest Business Overview
- 6.13.3 Biotest IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Biotest IVIg Liquid Product Portfolio
- 6.13.5 Biotest Recent Developments
7 North America by Country
- 7.1 North America IVIg Liquid Sales by Country
- 7.1.1 North America IVIg Liquid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America IVIg Liquid Sales by Country (2021-2026)
- 7.1.3 North America IVIg Liquid Sales Forecast by Country (2027-2032)
- 7.2 North America IVIg Liquid Market Size by Country
- 7.2.1 North America IVIg Liquid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America IVIg Liquid Market Size by Country (2021-2026)
- 7.2.3 North America IVIg Liquid Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe IVIg Liquid Sales by Country
- 8.1.1 Europe IVIg Liquid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe IVIg Liquid Sales by Country (2021-2026)
- 8.1.3 Europe IVIg Liquid Sales Forecast by Country (2027-2032)
- 8.2 Europe IVIg Liquid Market Size by Country
- 8.2.1 Europe IVIg Liquid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe IVIg Liquid Market Size by Country (2021-2026)
- 8.2.3 Europe IVIg Liquid Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific IVIg Liquid Sales by Country
- 9.1.1 Asia-Pacific IVIg Liquid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific IVIg Liquid Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific IVIg Liquid Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific IVIg Liquid Market Size by Country
- 9.2.1 Asia-Pacific IVIg Liquid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific IVIg Liquid Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific IVIg Liquid Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America IVIg Liquid Sales by Country
- 10.1.1 South America IVIg Liquid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America IVIg Liquid Sales by Country (2021-2026)
- 10.1.3 South America IVIg Liquid Sales Forecast by Country (2027-2032)
- 10.2 South America IVIg Liquid Market Size by Country
- 10.2.1 South America IVIg Liquid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America IVIg Liquid Market Size by Country (2021-2026)
- 10.2.3 South America IVIg Liquid Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa IVIg Liquid Sales by Country
- 11.1.1 Middle East and Africa IVIg Liquid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa IVIg Liquid Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa IVIg Liquid Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa IVIg Liquid Market Size by Country
- 11.2.1 Middle East and Africa IVIg Liquid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa IVIg Liquid Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa IVIg Liquid Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 IVIg Liquid Value Chain Analysis
- 12.1.1 IVIg Liquid Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 IVIg Liquid Production Mode & Process
- 12.2 IVIg Liquid Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 IVIg Liquid Distributors
- 12.2.3 IVIg Liquid Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst